WHO Expert Committee on Biological Standardization
İÇİNDEKİLERCONTENTS general ......................... pharmacological substances Antibiotics 1. Methacycline.................... 2. Neomycin B.................... 3. Neomycin..................... 4. Tetracycline..................... 5. Lymecycline.................... 6. Saramycetin..................... 7. Candicidin..................... 8. Trichomycin.................... 9. Penicillin K..................... 10. Clindamycin.................... 11. Minocycline..................... 12. Virginiamycin.................... 13. Anti-tumour antibiotics - bleomycin......... Hormones and enzymes 14. Glucagon...................... 15. Human growth hormone............... 16. Erythropoietin.................... 17. Human menopausal gonadotrophins.......... 18. Blood coagulation factor VIII (antihaemophilic factor) . immunological substances Antigens 19. Pertussis vaccine.................. 20. Measles vaccine (inactivated)............. 21. Lecithin (egg).................... 22. Rubella haemagglutinin............... 23. Clostridium oedematiens (type A) toxoid (adsorbed) . . . 24. Plague vaccine................... 25. Clostridium welchii (perfringens) types B and D vaccines 26. Epidemic typhus vaccine...............Antibodies 27. Anti-rubella serum........................ 28. Diphtheria antitoxin forflocculation test............. 29. Rheumatoid arthritis serum................... 30. Naja and other antivenins.................... 31. Gas-gangrene antitoxin (histolyticus)................ 32. Human immunoglobulins IgG, IgA and IgM........... 33. Human immunoglobulin IgD................... 34. Human immunoglobulin IgE................... 35. Anti-nuclear-factor serum (homogeneous)............. 36. Anti-Brucella abortus serum................... biological reference reagents 37. Anti-cholera sera . . . 38. Anti-leptospira sera . . 39. Anti-echinococcus serum international requirements for biological substances 40. Requirements for snake antivenins................ 41. Requirements for rubella vaccine................. 42. Requirements for procaine benzylpenicillin in oil with aluminium mono-stearate ............................. 43. Requirements for Brucella melitensis (rev. 1) vaccine........ 44. Requirements for poliomyelitis vaccine (oral)............ annexes Annex 1. Requirements for snake antivenins............... Annex 2. Requirements for biological substances and other sets of recommendations ............................. Annex 3. International biological standards and international biological reference preparations 1971....................... Annex 4. International biological reference reagents............ Annex 5. Proposed international biological standards, international biological reference preparations and international biological reference reagents Annex 6. Discontinued international biological standards.......... index  |
